NRX Pharmaceuticals, Inc. — 8-K/A Filings
5 8-K/A filings on record
This page lists all 8-K/A filings submitted to the SEC by NRX Pharmaceuticals, Inc. (NRXPW), sorted by most recent first. Each row links to the full filing on EdgarLookup. NRX Pharmaceuticals, Inc. has filed 5 8-K/A documents with the SEC since 2017. To view all SEC filings by NRX Pharmaceuticals, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
25-NSE
3
4
4/A
424B3
424B4
424B5
424B7
425
5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
D
DEF 14A
DEFA14A
EFFECT
NT 10-K
NT 10-Q
POS AM
POS EX
PRE 14A
PRER14A
RW
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K/A | FORM 8-K/A | 0001437749-25-036005 | Nov 21, 2025 | Sep 8, 2025 |
| 8-K/A | FORM 8-K/A | 0001104659-23-120777 | Nov 22, 2023 | Nov 15, 2023 |
| 8-K/A | FORM 8-K/A | 0001104659-23-068973 | Jun 7, 2023 | Jun 6, 2023 |
| 8-K/A | FORM 8-K/A | 0001104659-23-032019 | Mar 14, 2023 | Mar 9, 2023 |
| 8-K/A | CURRENT REPORT | 0001654954-21-000296 | Jan 11, 2021 | Jan 4, 2021 |